You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tyrosine Protein Kinase Inhibitors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

Recruiting
  • CML
  • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
  • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
    FUNDALEU
Jun 29, 2023

Tyrosine Kinase Inhibitors, Chronic Myeloid Leukemia Trial in Poitiers (treatment of TKI in CML)

Not yet recruiting
  • Tyrosine Kinase Inhibitors
  • Chronic Myeloid Leukemia
  • treatment of TKI in CML
  • Poitiers, France
    Chu Poitiers
Feb 21, 2023

Tyrosine Kinase Inhibitors on Liver Enzymes and Electrolytes

Active, not recruiting
  • Patients Diagnosed as Chronic Meyloid Leukemia
  • Tyrosine kinase Inhibitors (Imatinib & Nilotinib)
  • Assiut, Egypt
    Assiut University Hospital
Feb 19, 2022

Cancer Trial in Changsha (Protein Kinase Inhibitor)

Recruiting
  • Cancer
  • Protein Kinase Inhibitor
  • Changsha, Hunan, China
    Central South University
Jun 23, 2022

B-cell Malignancies Undergoing Treatment With Bruton Tyrosine

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Non-Interventional Study
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Nov 22, 2023

Atrial Fibrillation, Supraventricular Arrhythmia, Ventricular Arrhythmias and Cardiac Arrest Trial in New Hyde Park (Medtronic

Recruiting
  • Atrial Fibrillation
  • +4 more
  • Medtronic LINQ-2 Insertable Cardiac Monitor (ILR)
  • New Hyde Park, New York
    Northwell (Northshore University/Long Island Jewish Hospitals)
Dec 1, 2022

Non Small Cell Lung Cancer Trial in Mexico City (Metformin Hydrochloride, Placebo)

Recruiting
  • Non Small Cell Lung Cancer
  • Metformin Hydrochloride
  • Placebo
  • Mexico City, Mexico
    Instituto Nacional de Cancerologia
Jul 21, 2022

Non Small Cell Lung Cancer, Liquid Biopsy, Tyrosine Kinase Inhibitor Trial in Rotterdam

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
    • Rotterdam, Netherlands
      Erasmus MC
    Feb 2, 2022

    r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase

    Not yet recruiting
    • B-cell Lymphoma
    • Beijing, Beijing, China
      Deparment of Hematology, Peking University People's Hospital
    Aug 9, 2022

    Lung Tumor, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-701, osimertinib, carboplatin)

    Recruiting
    • Lung Neoplasm
    • +26 more
    • Boston, Massachusetts
    • +6 more
    Jun 23, 2022

    Olverembatinib, Chronic Myeloid Leukemia, Chronic Phase, Tyrosine Kinase Inhibitors Trial in Shenzhen (olverembatinib)

    Recruiting
    • Olverembatinib
    • +2 more
    • Shenzhen, Guangdong, China
      Shenzhen Second People's Hospital
    Jul 26, 2022

    Lung Cancer, Non Small Cell Lung Cancer Trial in Aurora (Amivantamab 1050mg, Amivantamab 1400mg, Amivantamab (to be determined))

    Not yet recruiting
    • Lung Cancer
    • Non Small Cell Lung Cancer
    • Amivantamab 1050mg
    • +2 more
    • Aurora, Colorado
    • +2 more
    Apr 25, 2023

    Leukemia, Lymphoma, Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial (BGB-11417)

    Not yet recruiting
    • Leukemia
    • +4 more
    • (no location specified)
    Jul 27, 2022

    Tyrosine Kinase Inhibitors in Trastuzumab Emtansine Resistant

    Recruiting
    • Breast Cancer
    • Nanjing, Jiangsu, China
      Jiangsu Provincial People's Hospital
    Feb 7, 2022

    Myeloproliferative Tumor, Chronic Phase Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (Online

    Recruiting
    • Myeloproliferative Neoplasm
    • +2 more
    • Online Mindfulness Meditation
    • Internet-Based Webinars
    • San Francisco, California
      University of California San Francisco
    Aug 9, 2022

    EGFR Activating Mutation, Recurrent Non-Small Cell Lung Carcinoma, Stage IV NSCLC Trial in Winston-Salem (drug, biological,

    Terminated
    • EGFR Activating Mutation
    • +2 more
    • Winston-Salem, North Carolina
      Comprehensive Cancer Center of Wake Forest University
    Jan 28, 2021

    The Life After Stopping Tyrosine Kinase Inhibitors Study

    Completed
    • Leukemia, Myeloid, Chronic
    • Imatinib (Stopping their TKI)
    • +3 more
    • San Francisco, California
    • +15 more
    Jan 3, 2023

    Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma, Neoadjuvant or Conversion Therapy, Precision Therapy Trial in

    Recruiting
    • Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma
    • +2 more
    • Beijing, Beijing, China
    • +1 more
    Nov 21, 2023

    Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Worldwide (procedure, other, drug)

    Recruiting
    • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • Biospecimen Collection
    • +4 more
    • Birmingham, Alabama
    • +170 more
    Jan 30, 2023

    Carcinoma, Adenoid Cystic Trial in Qingdao (EGFR-TK Inhibitor)

    Recruiting
    • Carcinoma, Adenoid Cystic
    • EGFR-TK Inhibitor
    • Qingdao, Shandong, China
      Qingdao central Hospital
    Nov 1, 2021

    NSCLC With EGFR Mutation Trial in Mexico City (Glutamine plus L. reuteri)

    Recruiting
    • Non-Small Cell Lung Cancer With EGFR Mutation
    • Glutamine plus L. reuteri
    • Mexico City, Mexico
      Instituto Nacional de Cancerologia de Mexico
    May 2, 2023

    NSCLC Stage IIIB~IV Trial in Taipei (Atezolizumab Injection; bevacizumab Injection)

    Recruiting
    • NSCLC Stage IIIB~IV
    • Atezolizumab Injection; bevacizumab Injection
    • Taipei, Taiwan
      National Taiwan University Hospital
    Jan 18, 2022

    Adult Chronic Lymphocytic Leukemia Receiving Oral Venetoclax

    Recruiting
    • Chronic Lymphocytic Leukemia
      • London, London, City Of, United Kingdom
      • +9 more
      Jan 13, 2023

      Cervical Cancer, Cervical Carcinoma Trial in Guangzhou (Zimberelimab, Lenvatinib)

      Not yet recruiting
      • Cervical Cancer
      • Cervical Carcinoma
      • Guangzhou, China
        Sun Yat-sen University Cancer Cetntre
      Apr 9, 2023

      Leukemia, Chronic Myelogenous Trial in China (asciminib, best available treatment)

      Recruiting
      • Leukemia, Chronic Myelogenous
      • Chongqing City, Chongqing, China
      • +23 more
      Jan 18, 2023